Literature DB >> 23065704

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.

Ali Amin Al Olama1, Zsofia Kote-Jarai, Fredrick R Schumacher, Fredrik Wiklund, Sonja I Berndt, Sara Benlloch, Graham G Giles, Gianluca Severi, David E Neal, Freddie C Hamdy, Jenny L Donovan, David J Hunter, Brian E Henderson, Michael J Thun, Michael Gaziano, Edward L Giovannucci, Afshan Siddiq, Ruth C Travis, David G Cox, Federico Canzian, Elio Riboli, Timothy J Key, Gerald Andriole, Demetrius Albanes, Richard B Hayes, Johanna Schleutker, Anssi Auvinen, Teuvo L J Tammela, Maren Weischer, Janet L Stanford, Elaine A Ostrander, Cezary Cybulski, Jan Lubinski, Stephen N Thibodeau, Daniel J Schaid, Karina D Sorensen, Jyotsna Batra, Judith A Clements, Suzanne Chambers, Joanne Aitken, Robert A Gardiner, Christiane Maier, Walther Vogel, Thilo Dörk, Hermann Brenner, Tomonori Habuchi, Sue Ingles, Esther M John, Joanne L Dickinson, Lisa Cannon-Albright, Manuel R Teixeira, Radka Kaneva, Hong-Wei Zhang, Yong-Jie Lu, Jong Y Park, Kathleen A Cooney, Kenneth R Muir, Daniel A Leongamornlert, Edward Saunders, Malgorzata Tymrakiewicz, Nadiya Mahmud, Michelle Guy, Koveela Govindasami, Lynne T O'Brien, Rosemary A Wilkinson, Amanda L Hall, Emma J Sawyer, Tokhir Dadaev, Jonathan Morrison, David P Dearnaley, Alan Horwich, Robert A Huddart, Vincent S Khoo, Christopher C Parker, Nicholas Van As, Christopher J Woodhouse, Alan Thompson, Tim Dudderidge, Chris Ogden, Colin S Cooper, Artitaya Lophatonanon, Melissa C Southey, John L Hopper, Dallas English, Jarmo Virtamo, Loic Le Marchand, Daniele Campa, Rudolf Kaaks, Sara Lindstrom, W Ryan Diver, Susan Gapstur, Meredith Yeager, Angela Cox, Mariana C Stern, Roman Corral, Markus Aly, William Isaacs, Jan Adolfsson, Jianfeng Xu, S Lilly Zheng, Tiina Wahlfors, Kimmo Taari, Paula Kujala, Peter Klarskov, Børge G Nordestgaard, M Andreas Røder, Ruth Frikke-Schmidt, Stig E Bojesen, Liesel M FitzGerald, Suzanne Kolb, Erika M Kwon, Danielle M Karyadi, Torben Falck Orntoft, Michael Borre, Antje Rinckleb, Manuel Luedeke, Kathleen Herkommer, Andreas Meyer, Jürgen Serth, James R Marthick, Briony Patterson, Dominika Wokolorczyk, Amanda Spurdle, Felicity Lose, Shannon K McDonnell, Amit D Joshi, Ahva Shahabi, Pedro Pinto, Joana Santos, Ana Ray, Thomas A Sellers, Hui-Yi Lin, Robert A Stephenson, Craig Teerlink, Heiko Muller, Dietrich Rothenbacher, Norihiko Tsuchiya, Shintaro Narita, Guang-Wen Cao, Chavdar Slavov, Vanio Mitev, Stephen Chanock, Henrik Gronberg, Christopher A Haiman, Peter Kraft, Douglas F Easton, Rosalind A Eeles.   

Abstract

Genome-wide association studies (GWAS) have identified multiple common genetic variants associated with an increased risk of prostate cancer (PrCa), but these explain less than one-third of the heritability. To identify further susceptibility alleles, we conducted a meta-analysis of four GWAS including 5953 cases of aggressive PrCa and 11 463 controls (men without PrCa). We computed association tests for approximately 2.6 million SNPs and followed up the most significant SNPs by genotyping 49 121 samples in 29 studies through the international PRACTICAL and BPC3 consortia. We not only confirmed the association of a PrCa susceptibility locus, rs11672691 on chromosome 19, but also showed an association with aggressive PrCa [odds ratio = 1.12 (95% confidence interval 1.03-1.21), P = 1.4 × 10(-8)]. This report describes a genetic variant which is associated with aggressive PrCa, which is a type of PrCa associated with a poorer prognosis.

Entities:  

Mesh:

Year:  2012        PMID: 23065704      PMCID: PMC3526158          DOI: 10.1093/hmg/dds425

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  17 in total

1.  A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study.

Authors:  S Lilly Zheng; Wennuan Liu; Fredrik Wiklund; Latchezar Dimitrov; Katarina Bälter; Jielin Sun; Hans-Olov Adami; Jan-Erik Johansson; Jishan Sun; Baoli Chang; Matthew Loza; Aubrey R Turner; Eugene R Bleecker; Deborah A Meyers; John D Carpten; David Duggan; William B Isaacs; Jianfeng Xu; Henrik Grönberg
Journal:  Prostate       Date:  2006-10-01       Impact factor: 4.104

2.  GenABEL: an R library for genome-wide association analysis.

Authors:  Yurii S Aulchenko; Stephan Ripke; Aaron Isaacs; Cornelia M van Duijn
Journal:  Bioinformatics       Date:  2007-03-23       Impact factor: 6.937

3.  Genome-wide association study identifies new prostate cancer susceptibility loci.

Authors:  Fredrick R Schumacher; Sonja I Berndt; Afshan Siddiq; Kevin B Jacobs; Zhaoming Wang; Sara Lindstrom; Victoria L Stevens; Constance Chen; Alison M Mondul; Ruth C Travis; Daniel O Stram; Rosalind A Eeles; Douglas F Easton; Graham Giles; John L Hopper; David E Neal; Freddie C Hamdy; Jenny L Donovan; Kenneth Muir; Ali Amin Al Olama; Zsofia Kote-Jarai; Michelle Guy; Gianluca Severi; Henrik Grönberg; William B Isaacs; Robert Karlsson; Fredrik Wiklund; Jianfeng Xu; Naomi E Allen; Gerald L Andriole; Aurelio Barricarte; Heiner Boeing; H Bas Bueno-de-Mesquita; E David Crawford; W Ryan Diver; Carlos A Gonzalez; J Michael Gaziano; Edward L Giovannucci; Mattias Johansson; Loic Le Marchand; Jing Ma; Sabina Sieri; Pär Stattin; Meir J Stampfer; Anne Tjonneland; Paolo Vineis; Jarmo Virtamo; Ulla Vogel; Stephanie J Weinstein; Meredith Yeager; Michael J Thun; Laurence N Kolonel; Brian E Henderson; Demetrius Albanes; Richard B Hayes; Heather Spencer Feigelson; Elio Riboli; David J Hunter; Stephen J Chanock; Christopher A Haiman; Peter Kraft
Journal:  Hum Mol Genet       Date:  2011-07-08       Impact factor: 6.150

4.  Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.

Authors:  Liesel M FitzGerald; Erika M Kwon; Matthew P Conomos; Suzanne Kolb; Sarah K Holt; David Levine; Ziding Feng; Elaine A Ostrander; Janet L Stanford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-05       Impact factor: 4.254

5.  Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.

Authors:  Daniel W Lin; Liesel M FitzGerald; Rong Fu; Erika M Kwon; Siqun Lilly Zheng; Suzanne Kolb; Fredrik Wiklund; Pär Stattin; William B Isaacs; Jianfeng Xu; Elaine A Ostrander; Ziding Feng; Henrik Grönberg; Janet L Stanford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-16       Impact factor: 4.254

6.  ProbABEL package for genome-wide association analysis of imputed data.

Authors:  Yurii S Aulchenko; Maksim V Struchalin; Cornelia M van Duijn
Journal:  BMC Bioinformatics       Date:  2010-03-16       Impact factor: 3.169

7.  A novel prostate cancer susceptibility locus at 19q13.

Authors:  Fang-Chi Hsu; Jielin Sun; Fredrik Wiklund; Sarah D Isaacs; Kathleen E Wiley; Lina D Purcell; Zhengrong Gao; Pär Stattin; Yi Zhu; Seong-Tae Kim; Zheng Zhang; Wennuan Liu; Bao-Li Chang; Patrick C Walsh; David Duggan; John D Carpten; William B Isaacs; Henrik Grönberg; Jianfeng Xu; S Lilly Zheng
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

8.  Functional dissection of the human TNRC6 (GW182-related) family of proteins.

Authors:  David Baillat; Ramin Shiekhattar
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

9.  Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.

Authors:  Rosalyn D Blumenthal; Evelyn Leon; Hans J Hansen; David M Goldenberg
Journal:  BMC Cancer       Date:  2007-01-03       Impact factor: 4.430

10.  Identification of a new prostate cancer susceptibility locus on chromosome 8q24.

Authors:  Meredith Yeager; Nilanjan Chatterjee; Julia Ciampa; Kevin B Jacobs; Jesus Gonzalez-Bosquet; Richard B Hayes; Peter Kraft; Sholom Wacholder; Nick Orr; Sonja Berndt; Kai Yu; Amy Hutchinson; Zhaoming Wang; Laufey Amundadottir; Heather Spencer Feigelson; Michael J Thun; W Ryan Diver; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; E David Crawford; Christopher A Haiman; Brian Henderson; Laurence Kolonel; Loic Le Marchand; Afshan Siddiq; Elio Riboli; Timothy J Key; Rudolf Kaaks; William Isaacs; Sarah Isaacs; Kathleen E Wiley; Henrik Gronberg; Fredrik Wiklund; Pär Stattin; Jianfeng Xu; S Lilly Zheng; Jielin Sun; Lars J Vatten; Kristian Hveem; Merethe Kumle; Margaret Tucker; Daniela S Gerhard; Robert N Hoover; Joseph F Fraumeni; David J Hunter; Gilles Thomas; Stephen J Chanock
Journal:  Nat Genet       Date:  2009-09-20       Impact factor: 38.330

View more
  71 in total

1.  Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.

Authors:  Rayjean J Hung; Cornelia M Ulrich; Ellen L Goode; Yonathan Brhane; Kenneth Muir; Andrew T Chan; Loic Le Marchand; Joellen Schildkraut; John S Witte; Rosalind Eeles; Paolo Boffetta; Margaret R Spitz; Julia G Poirier; David N Rider; Brooke L Fridley; Zhihua Chen; Christopher Haiman; Fredrick Schumacher; Douglas F Easton; Maria Teresa Landi; Paul Brennan; Richard Houlston; David C Christiani; John K Field; Heike Bickeböller; Angela Risch; Zsofia Kote-Jarai; Fredrik Wiklund; Henrik Grönberg; Stephen Chanock; Sonja I Berndt; Peter Kraft; Sara Lindström; Ali Amin Al Olama; Honglin Song; Catherine Phelan; Nicholas Wentzensen; Ulrike Peters; Martha L Slattery; Thomas A Sellers; Graham Casey; Stephen B Gruber; David J Hunter; Christopher I Amos; Brian Henderson
Journal:  J Natl Cancer Inst       Date:  2015-08-29       Impact factor: 13.506

2.  Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis.

Authors:  Shafat Ali; Yilan Zhang; Mian Zhou; Hongzhi Li; Weiwei Jin; Li Zheng; Xiaochun Yu; Jeremy M Stark; Jeffrey N Weitzel; Binghui Shen
Journal:  Oncogene       Date:  2019-10-15       Impact factor: 9.867

Review 3.  A multiparametric approach to improve upon existing prostate cancer screening and biopsy recommendations.

Authors:  Brian T Helfand; Carly A Conran; Jianfeng Xu; William J Catalona
Journal:  Curr Opin Urol       Date:  2017-09       Impact factor: 2.309

4.  Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.

Authors:  Brian T Helfand; Kimberly A Roehl; Phillip R Cooper; Barry B McGuire; Liesel M Fitzgerald; Geraldine Cancel-Tassin; Jean-Nicolas Cornu; Scott Bauer; Erin L Van Blarigan; Xin Chen; David Duggan; Elaine A Ostrander; Mary Gwo-Shu; Zuo-Feng Zhang; Shen-Chih Chang; Somee Jeong; Elizabeth T H Fontham; Gary Smith; James L Mohler; Sonja I Berndt; Shannon K McDonnell; Rick Kittles; Benjamin A Rybicki; Matthew Freedman; Philip W Kantoff; Mark Pomerantz; Joan P Breyer; Jeffrey R Smith; Timothy R Rebbeck; Dan Mercola; William B Isaacs; Fredrick Wiklund; Olivier Cussenot; Stephen N Thibodeau; Daniel J Schaid; Lisa Cannon-Albright; Kathleen A Cooney; Stephen J Chanock; Janet L Stanford; June M Chan; John Witte; Jianfeng Xu; Jeannette T Bensen; Jack A Taylor; William J Catalona
Journal:  Hum Genet       Date:  2015-02-26       Impact factor: 4.132

5.  A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.

Authors:  Thomas J Hoffmann; Stephen K Van Den Eeden; Lori C Sakoda; Eric Jorgenson; Laurel A Habel; Rebecca E Graff; Michael N Passarelli; Clinton L Cario; Nima C Emami; Chun R Chao; Nirupa R Ghai; Jun Shan; Dilrini K Ranatunga; Charles P Quesenberry; David Aaronson; Joseph Presti; Zhaoming Wang; Sonja I Berndt; Stephen J Chanock; Shannon K McDonnell; Amy J French; Daniel J Schaid; Stephen N Thibodeau; Qiyuan Li; Matthew L Freedman; Kathryn L Penney; Lorelei A Mucci; Christopher A Haiman; Brian E Henderson; Daniela Seminara; Mark N Kvale; Pui-Yan Kwok; Catherine Schaefer; Neil Risch; John S Witte
Journal:  Cancer Discov       Date:  2015-06-01       Impact factor: 39.397

6.  Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.

Authors:  David C Qian; Jinyoung Byun; Younghun Han; Casey S Greene; John K Field; Rayjean J Hung; Yonathan Brhane; John R Mclaughlin; Gordon Fehringer; Maria Teresa Landi; Albert Rosenberger; Heike Bickeböller; Jyoti Malhotra; Angela Risch; Joachim Heinrich; David J Hunter; Brian E Henderson; Christopher A Haiman; Fredrick R Schumacher; Rosalind A Eeles; Douglas F Easton; Daniela Seminara; Christopher I Amos
Journal:  Hum Mol Genet       Date:  2015-10-19       Impact factor: 6.150

Review 7.  Genomic approaches to accelerate cancer interception.

Authors:  Jennifer Beane; Joshua D Campbell; Julian Lel; Jessica Vick; Avrum Spira
Journal:  Lancet Oncol       Date:  2017-07-26       Impact factor: 41.316

8.  Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.

Authors:  Ping Gao; Ji-Han Xia; Csilla Sipeky; Xiao-Ming Dong; Qin Zhang; Yuehong Yang; Peng Zhang; Sara Pereira Cruz; Kai Zhang; Jing Zhu; Hang-Mao Lee; Sufyan Suleman; Nikolaos Giannareas; Song Liu; Teuvo L J Tammela; Anssi Auvinen; Xiaoyue Wang; Qilai Huang; Liguo Wang; Aki Manninen; Markku H Vaarala; Liang Wang; Johanna Schleutker; Gong-Hong Wei
Journal:  Cell       Date:  2018-07-19       Impact factor: 41.582

9.  Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.

Authors:  Jennifer A Freedman; Yanru Wang; Xuechan Li; Hongliang Liu; Patricia G Moorman; Daniel J George; Norman H Lee; Terry Hyslop; Qingyi Wei; Steven R Patierno
Journal:  Carcinogenesis       Date:  2018-07-03       Impact factor: 4.944

10.  Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.

Authors:  Weiqiang Li; Mridu Middha; Mesude Bicak; Daniel D Sjoberg; Emily Vertosick; Anders Dahlin; Christel Häggström; Göran Hallmans; Ann-Charlotte Rönn; Pär Stattin; Olle Melander; David Ulmert; Hans Lilja; Robert J Klein
Journal:  Eur Urol       Date:  2018-07-07       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.